Re: Cost-Effectiveness of Combination Therapy for Treatment of Benign Prostatic Hyperplasia: A Model Based on the Findings of the Combination of Avodart and Tamsulosin Trial Editorial Comment

被引：0
|
作者：
Kaplan, Steven A.
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 188卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.06.081
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1237 / 1238
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of combination therapy for treatment of benign prostatic hyperplasia: a model based on the findings of the Combination of Avodart and Tamsulosin trial
    Johansen, Truls E. Bjerklund
    Baker, Timothy M.
    Black, Libby K.
    [J]. BJU INTERNATIONAL, 2012, 109 (05) : 731 - 738
  • [2] COST-EFFECTIVENESS ANALYSIS OF DUTASTERIDE, TAMSULOSIN AND COMBINATION THERAPY IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    Bang, S., I
    Hay, J.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A78 - A78
  • [3] Cost-effectiveness of dutasteride-tamsulosin combination therapy for the treatment of symptomatic benign prostatic hyperplasia: A Canadian model based on the CombAT trial
    Ismaila, Afisi
    Walker, Anna
    Sayani, Amyn
    Laroche, Bruno
    Nickel, J. Curtis
    Posnett, John
    Su, Zhen
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (5-6): : E393 - E401
  • [4] COST-EFFECTIVENESS OF COMBINATION THERAPY FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    Baker, T. M.
    Black, L.
    Bjerklund, Johansen T. E.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A309 - A309
  • [5] Comment to: "Cost-Effectiveness of the combination therapy of dutasteride and tamsulosin in the treatment of benign prostatic hyperlasia in Spain"
    Minana, B.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2011, 35 (02): : 72 - 72
  • [6] Cost-Effectiveness of the Combination Therapy of Dutasteride and Tamsulosin in the Treatment of Benign Prostatic Hyperlasia in Spain
    Antonanzas, F.
    Brenes, F.
    Molero, J. M.
    Fernandez-Pro, A.
    Huerta, A.
    Palencia, R.
    Cozar, J. M.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2011, 35 (02): : 65 - 71
  • [7] Cost-effectiveness of single-dose tamsulosin and dutasteride combination therapy compared with tamsulosin monotherapy in patients with benign prostatic hyperplasia in the UK
    Walker, Anna
    Doyle, Scott
    Posnett, John
    Hunjan, Manjit
    [J]. BJU INTERNATIONAL, 2013, 112 (05) : 638 - 646
  • [8] Cost-effectiveness of tamsulosin, doxazosin and terazosin in the treatment of benign prostatic hyperplasia
    Ohsfeldt, RL
    Kreder, KJ
    Klein, R
    Chrischilles, EC
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 288 - 288
  • [9] Cost-effectiveness of tamsulosin, doxazosin and terazosin in the treatment of benign prostatic hyperplasia
    Ohsfeldt, RL
    Kreder, KJ
    Klein, RW
    Chrischilles, EA
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 345 - 345
  • [10] EFFECT OF DUTASTERIDE ON THE DETECTION OF PROSTATE CANCER IN MEN WITH BENIGN PROSTATIC HYPERPLASIA IN THE COMBINATION OF AVODART AND TAMSULOSIN (COMBAT) TRIAL
    Roehrborn, C. G.
    Tubaro, A.
    Barkin, J.
    Wilson, T. H.
    Gagnier, R. P.
    Castro, R.
    Rittmaster, R. S.
    [J]. JOURNAL OF MENS HEALTH, 2009, 6 (03) : 268 - 268
12345